光大证券研究·2025-07-10 16:07Group 1 - The article discusses the market outlook for the second half of 2025, indicating a shift from policy-driven to fundamental and liquidity-driven market dynamics, with expectations of a new upward trend that may surpass the peak of the second half of 2024 [4] - The article highlights the performance of Northern Rare Earth, which anticipates a net profit of 0.9 to 0.96 billion yuan for the first half of 2025, representing a year-on-year increase of 1882.54% to 2014.71%, driven by rising prices of praseodymium-neodymium and lanthanum-cerium, along with reduced processing costs [5] - The article notes that Juhua Co. expects a net profit of 1.97 to 2.13 billion yuan for the first half of 2025, reflecting a year-on-year growth of 136% to 155%, with Q2 profits projected to be 1.16 to 1.32 billion yuan, marking a year-on-year increase of 122% to 152% [6] - Zoli Pharmaceutical forecasts a net profit of 0.368 to 0.388 billion yuan for the first half of 2025, indicating a year-on-year growth of 24% to 31%, with Q2 profits expected to be 0.187 to 0.207 billion yuan, showing a year-on-year increase of 21% to 34% [7]